Welcome to LookChem.com Sign In|Join Free

CAS

  • or

77826-00-7

Post Buying Request

77826-00-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77826-00-7 Usage

General Description

"(11beta)-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione" is a chemical compound belonging to the class of corticosteroids. It is a derivative of the natural hormone cortisol and is typically used as a pharmaceutical drug to reduce inflammation and suppress the immune system. (11beta)-11-hydroxy-17,21-epoxypregn-4-ene-3,20-dione has potent anti-inflammatory and immunosuppressive properties, making it useful for treating conditions such as allergies, asthma, rheumatoid arthritis, and inflammatory bowel diseases. However, it also comes with potential side effects such as weight gain, fluid retention, and increased susceptibility to infections. Therefore, it should be used under the supervision of a healthcare professional.

Check Digit Verification of cas no

The CAS Registry Mumber 77826-00-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,8,2 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 77826-00:
(7*7)+(6*7)+(5*8)+(4*2)+(3*6)+(2*0)+(1*0)=157
157 % 10 = 7
So 77826-00-7 is a valid CAS Registry Number.

77826-00-7Downstream Products

77826-00-7Relevant articles and documents

Raw synthesis and mitochondrial function postischemic mitochondria diseases related to the lack or for use in new compd. 11β-hydroxysteroid

-

Paragraph 0249, (2016/10/08)

The present invention provides novel compounds of 112-hydroxy steroids and compositions and their application as pharmaceuticals for preventing or reversing injury to mitochondria, for treating or preventing diseases relating to mitochondrial dysfunction or depletion, and for inducing regeneration or restructuring of mitochondria as a means of treating diseases relating to abnormalities in mitochondrial structure and function in a human or animal subject. Also disclosed herein are methods for diagnosing injury to mitochondria and for diagnosing the success or failure of therapeutics designed to treat, prevent, or reverse injury to or depletion of mitochondria.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 77826-00-7